Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myeloma by Wassilis S. C. Bruins, Rosa Rentenaar, John Newcomb, Wenrou Zheng, Ruud W. J. Ruiter, Thomas Baardemans, Eric Poma, Chris Moore, Garrett L. Robinson, Anya Lublinsky, Yuhong Zhang, Sakeena Syed, Michael Milhollen, Ajeeta B. Dash, Niels W. C. J. van deDonk, Richard W. J. Groen, Sonja Zweegman, Tuna Mutis

Get full text